Innate Pharma SA (NAS:IPHA)
$ 1.9 0.05 (2.7%) Market Cap: 153.81 Mil Enterprise Value: 93.89 Mil PE Ratio: 0 PB Ratio: 4.75 GF Score: 56/100

Q3 2021 Innate Pharma SA Corporate Sales Call Transcript

Nov 16, 2021 / 01:00PM GMT
Release Date Price: $5.29 (+1.93%)
Operator

Good afternoon, ladies and gentlemen, and welcome to Innate Pharma's Third Quarter 2021 Business Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. (Operator Instructions) I will now hand over to Innate Pharma's Chairman of the Executive Board and Chief Executive Officer, Mondher Mahjoubi. Please go ahead, sir.

Mondher Mahjoubi
Innate Pharma S.A. - Chairman of Executive Board & CEO

Thank you. Good morning, good afternoon, and welcome, everyone. This morning, we issued a press release providing a business update for the third quarter of 2021. I look forward to explaining the progress we made during the year to date as well as address some future goals and milestones. The press release and today's presentation are both available on the IR section of our website.

Please move to Slide #2. And before we start, I would like to remind you that we will make forward-looking statements regarding the financial outlook in addition to regulatory and product plan development. These statements are subject to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot